Why Do People With Similar Symptoms Respond Differently to Mental Health Medications?

Mental health conditions are traditionally diagnosed based on symptoms. While this approach remains extremely valuable, it does not always explain why two people with very similar symptoms can have very different experiences with the same medication.

One person may experience significant improvement, another may notice little benefit, while a third may develop troublesome side effects.

Why does this happen?

The answer may lie in the underlying neurochemistry of the brain.

Looking Beyond Symptoms

Many symptoms of depression, anxiety, ADHD, and other mental health conditions can be linked to changes in the activity of three key neurotransmitters:

• Serotonin – involved in emotional stability, stress resilience, and mood regulation.
• Dopamine – involved in motivation, reward, focus, and executive functioning.
• Norepinephrine – involved in alertness, attention, energy, and the body's stress response.

Although people may report similar symptoms, the underlying neurotransmitter dysregulation may be very different.

For example:

• Reduced dopamine activity in the prefrontal cortex may contribute to low motivation, poor concentration, impaired executive functioning, and a reduced ability to experience pleasure.
• Reduced serotonin activity may contribute to excessive worrying, emotional sensitivity, rumination, and reduced resilience to stress.

As a result, two individuals who both describe feeling "depressed" or "anxious" may actually have very different underlying neurochemical patterns and may therefore benefit from different treatment approaches.

Symptoms Can Reflect Different Neurochemical Patterns

The relationship between symptoms and neurotransmitters is often complex.

For example, a person who reports that they are constantly worrying may be experiencing:

• Reduced serotonin activity in the prefrontal cortex
• Excessive norepinephrine activity in the amygdala
• Reduced norepinephrine activity in the prefrontal cortex
• Or a combination of several neurochemical factors

This illustrates why symptoms alone do not always reveal the full picture.

Why Neurochemistry Matters in Treatment

Most psychiatric medications work by increasing or modulating serotonin, dopamine, norepinephrine, or a combination of these neurotransmitters.

To select the most appropriate treatment, it is helpful to understand which neurotransmitter systems may be contributing to a person's symptoms.

The goal is not simply to treat a diagnosis, but to better understand the underlying neurochemical patterns that may be driving the symptoms.

Introducing NeuroMapp™

To help address this challenge, we developed NeuroMapp™, a structured symptom assessment designed to identify patterns of possible neurotransmitter dysregulation.

NeuroMapp™ evaluates symptom clusters and examines how they may relate to activity within key brain regions involved in mood, cognition, attention, motivation, and emotional regulation.

The assessment estimates whether neurotransmission within these regions may currently be functioning in a:

• Low state
• Balanced state
• Elevated state

An Important Note

NeuroMapp™ does not directly measure neurotransmitter levels in the brain.

Currently, there are no practical clinical tests that can accurately measure real-time neurotransmitter activity within specific brain regions.

Instead, NeuroMapp™ uses a scientifically informed modeling approach that analyzes symptom patterns and applies established relationships between symptoms, brain regions, and neurotransmitter function to identify likely patterns of neurochemical dysregulation.

By providing a deeper understanding of how symptoms may relate to brain chemistry, NeuroMapp™ helps support a more personalized approach to mental health care.

Understanding the "why" behind symptoms may be an important step toward finding the treatment strategy that is right for each individual.